Calcifediol Monohydrate Market Size 2021 By Industry Share, Key Findings, Company Profiles, Growth Strategy, Developing Technologies, Demand, Investment Opportunities and Forecast by Regions till 2030

In a recent published report, Kenneth Research has updated the market report for Calcifediol Monohydrate Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Calcifediol Monohydrate Market products.

Download  Sample of This Strategic Report-https://www.kennethresearch.com/sample-request-10294061

REPORT HIGHLIGHT

The calcifediol monohydrate acid was valued at USD 31,800 thousand by 2017, growing with 5.4% CAGR during the forecast period, 2018-2025.

Calcifediol monohydrate (25-Hydroxyvitamin D3) is a prehormone or vitamin D3 analogue, which is produced by hydroxylation of vitamin D3 (cholecalciferol) through the utilization of enzyme cholecalciferol 25-hydroxylase. Rising spending on Advanced Pharmaceutical Ingredients (API) manufacturing in the emrging economies including, China and India is projected to remain a favorable factor for the Calcifediol monohydrate market. For instance, investment in production of vitamin D analogues is likely to remain a key trend on account of their increasing visibility as an ingredient with good gene regulatory properties. For instance, Dishman Group owned a vitamin D analogue manufacturing facility in the Netherlands in 2017. The company is planning to expand the production capacity of vitamin D analogues including, calcifediol monohydrate in India in order to cater the growing demand from animal feed and pharma sectors.

Furthermore, rising prevalance of chronic kidney disese (CKD) on a global level as a result of fluctuating diet patterns and hectic workstyle is driving the growth of calcifediol monohydrate-based drugs. For instance, according to National Center for Chronic Disease Prevention and Health Promotion (USA), around 15% of the total U.S. population is suffering from chronic kidney disease (CKD).

In addition, rising prevalence of rickets and osteomalacia is expected to provide growth opportunity for this industry. For instance, according to The Centers for Disease Control and Prevention, 5 per 1,000,000 children aged between 6 months and 5 years have rickets. On contrary, the production of this chemical involves technological advanced machinery owing to its high concentration and purity of vitamin D, hampering the market growth to some extent.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Application Takeaway

Global calcifediol monohydrate market is segmented on the basis of three application segments including, animal feed, pharmaceutical, and others. Others application segment covers the use of calcifediol monohydrate in personal care and nutraceutical applications. Among animal industry, species such as broilers, cattle, breeders, and swine are expected to use calcifediol monohydrate as a key source for the calcium and phosphorus absorption in the body and mobilisation of calcium in bones. In addition, it also helps in improving the immune cells.

Request For Full Report-https://www.kennethresearch.com/sample-request-10294061

Regional Takeaway

Asia Pacific is accounted for the largest market, accounting for over 50% of global calcifediol monohydrate market. In the region, animal feed accounted for 95% of the produced volume of calcifediol monohydrate. Increasing production of livestock in the region is expected to fuel the demand for animal feed. Europe is considered to be the second largest consumer of calcifediol monohydrate. The region is expected to witness a high growth rate on account of rising prevalence of kidney disorders.

Key Vendors Takeaway

Dishman Group

Chemvon Biotechnology Co

Haoyuan Chemexpress Co., Ltd

Pharmaceutical Research Institute (PRI)

Companies are actively engaged in research and development activities. Major manufacturers of vitamin D and vitamin D2 including Chemvon Biotechnology, and Dishman Group owned technology to produce the calcifediol. In addition, it is noted that key manufacturers are installing their manufacturing facilities in the Europe due to the favorable regulations regarding manufacturing and marketing of Vitamin D analogues and Vitamin D3 APIs.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year – 2014 & 2016

Base Year – 2017

Estimated Year – 2018

Projected Year – 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY APPLICATION

Animal Feed

Pharmaceutical

Others

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name: Kenneth research

Email:sales@kennethresearch.com

Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply